• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-25

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to support PCR product contamination elimination and controlled DNA damage repair research. It is intended for research workflows involving DNA, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.

• Prednisolone: Glucocorticoid Research Guide

  2026-08-25

  Prednisolone is a synthetic glucocorticoid for controlled studies of glucocorticoid receptor signaling, inflammation modulation, and immune-cell responses. Its documented activity should be distinguished from the desonide-based ERAD-engaging chimeras reported for targeted transmembrane-protein degradation.

• Minoxidil Sulphate: Mechanism to Assay Design

  2026-08-24

  Explore how Minoxidil sulphate can function as a mechanistic probe in vascular biology research. This article translates renal hemodynamic findings into a rigorous framework for distinguishing potassium-channel activity, tissue context, and assay-specific responses.

• SGI-1027 Regulates RB1 via DNMT1 in Gastric Cancer

  2026-08-23

  A 2024 Discovery Medicine study identifies a DNMT1–RB1 regulatory axis through which SGI-1027 suppresses gastric cancer cell proliferation, migration, invasion, and xenograft progression. Its integrated cell and mouse experiments provide a mechanistic framework for studying DNA methylation inhibition and tumor suppressor gene reactivation, while also highlighting limits in translating MKN45-based findings to broader cancer models.

• Silymarin Workflows for Translational Research

  2026-08-22

  Turn Silymarin, a chemically diverse milk thistle extract, into a controlled probe for oxidative stress, cancer, metabolic, and antiviral experiments. This workflow emphasizes stock preparation, batch-aware assay design, orthogonal readouts, and troubleshooting that separates genuine biology from solubility or vehicle artifacts.

• MMP-2-Responsive Peptide Nanocarriers in Breast Cancer

  2026-08-21

  The reference study developed a self-assembling peptide system that responds to tumor-associated MMP-2 by transforming its morphology while co-delivering doxorubicin and indomethacin. This design improved tumor-cell drug retention, increased immunogenic cell death, moderated tumor-associated inflammation, and enhanced breast cancer suppression in the reported experimental models.

• PSMD14–CARM1 Signaling in Hepatocellular Carcinoma

  2026-08-21

  This study identifies a PSMD14–CARM1–FERMT1 axis that promotes hepatocellular carcinoma growth and metastasis. Its findings connect deubiquitination, histone arginine methylation, and transcriptional activation, while highlighting CARM1 inhibition as a mechanistically supported strategy for further investigation.

• Cyanine 5-dCTP for Reliable DNA Labeling

  2026-08-20

  Cyanine 5-dCTP (SKU B8161) supports fluorescent DNA labeling for PCR, probe synthesis, and nucleic acid detection workflows that complement cell viability, proliferation, and cytotoxicity assays. This scenario-based guide explains compatibility, handling, interpretation, and vendor-selection considerations using documented product specifications and relevant enzymatic synthesis evidence.

• GPNMB Model Predicts Immunotherapy Response in ESCC

  2026-08-20

  The reference study identifies circulating soluble GPNMB as a mechanistically linked biomarker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors develop a multimodal framework intended to improve response prediction and patient stratification.

• Mn–mRNA Nanoparticles for Higher-Capacity Vaccines

  2026-08-19

  The reference study introduces a manganese-mediated condensation strategy that creates dense mRNA cores before lipid coating, nearly doubling mRNA loading and improving cellular uptake relative to conventional LNP–mRNA formulations. Its findings support a dose-sparing design principle for lipid-based vaccines, while also identifying experimental considerations for translating the platform to other mRNA payloads and delivery workflows.

• DeferoxamineB Workflows for Iron-Dependent Cell Death

  2026-08-19

  DeferoxamineB provides a practical iron-chelation control for separating iron-dependent cytotoxicity from copper-driven effects in cancer and metabolic assays. This workflow combines preparation guidance, timing strategies, orthogonal readouts, and troubleshooting for more reproducible studies of ferroptosis, apoptosis, autophagy, and tumor-cell metabolism.

• Self-Adaptive Nanocarriers in Pancreatic Cancer

  2026-08-18

  The ACS Nano study developed a pH/reactive oxygen species dual-sensitive nanocarrier that exposes arginine in the acidic pancreatic tumor microenvironment, generates peroxynitrite, remodels extracellular matrix, and improves camptothecin delivery. Its significance lies in integrating circulation, tumor penetration, drug release, and metastasis-related biology within one adaptive platform, while also highlighting the need for carefully interpreted ROS measurements.

• Valemetostat and the Translational Logic of EZH1/2 Inhibitio

  2026-08-18

  Valemetostat, also known as DS-3201, illustrates how genotype-aware EZH2 inhibition can be translated from biochemical selectivity into lymphoma research strategy. This thought-leadership article connects PRC2 biology, assay design, clinical signals, product handling, and a carefully bounded lesson from berberrubine research without treating cross-disease evidence as proof of efficacy.

• DNA Damage Response in Calicheamicin ADC Sensitivity

  2026-08-17

  The reference study combines genome-wide CRISPR/Cas9 screening with pharmacologic and isogenic validation to identify DNA damage-response determinants of calicheamicin sensitivity in acute leukemia. TP53, ATM, and MDM2 emerged as actionable modulators, whereas PARP inhibition did not broadly enhance calicheamicin cytotoxicity, emphasizing the importance of context-specific combination strategies.

• Trolox: A Mechanistic Guide to Redox Assays

  2026-08-16

  Trolox is more than a general antioxidant standard: it can help researchers distinguish broad redox protection from lipid-specific injury. This guide integrates Trolox chemistry with ferroptosis research to improve assay interpretation, controls, and experimental design.

454 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page